MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Increased bilirubin levels in Parkinson’s disease from southern Spain.

    D. Macias Garcia, D. Macias Garcia, C. Mendez Barrio, S. Jesus, M.A. Labrador Espinosa, M. Bernal Escudero, L. Vargas Gonzalez, A. Adarmes Gomez, F. Carrillo, M. Carballo, P. Gómez-Garre, P. Mir (Seville, Spain)

    Objective: To evaluate serum bilirubin concentration in Parkinson’s disease (PD) compared to healthy controls (HC) and to investigate its associations with motor and non-motor features…
  • 2017 International Congress

    Catecholamines’ concentration ratio in plasma of early diagnosed treatment-naive patients with Parkinson disease

    Z. Zalyalova, D. Khasanova (Kazan, Russian Federation)

    Objective: To investigate the concentration of some catecholamines (dopamine, DOPA and DOPAC) in the blood plasma and their ratio to each other depending on sex, form and…
  • 2017 International Congress

    Intracortical plasticity is preserved in de novo Parkinson’s disease: a tSMS study.

    M. Dileone, V. Catanzaro, J. Obeso, G. Foffani (Mostoles, Spain)

    Objective: To test the intracortical plasticity of motor cortex in treatment-naïve (de novo) patients with Parkinson’s disease (PD), by means of transcranial static magnetic field…
  • 2017 International Congress

    The comparison of urine microvesicle reflecting gut microbiome between Parkinson’s disease and healthy control

    J. Park, S. Park, W. Jang, J.S. Kim, J. Yoon, E. Oh (Busan, Republic of Korea)

    Objective: The objective of this study to compare urine microvesicle between Parkinson’s disease(PD) and healthy controls Background: Recent researches showed that gut microbiome interact with central…
  • 2017 International Congress

    Neurological worsening in patients undergoing treatment for Wilson disease: Frequency, causes and outcomes.

    A. Aggarwal, M. Bhatt (Mumbai, India)

    Objective: To study the pattern of neurological worsening (NW) in patients undergoing treatment for Wilson disease (WD). Background: WD is an inherited disorder of copper…
  • 2017 International Congress

    Multiple myeloma induced parkinsonism

    H. DS, V. Paramanandam, P.c. N (Chennai, India)

    Objective: AHyper calcemia induced parkinsonism is one of the reversible parkinsonism with few reported cases. To our knowledge, Parkinsonism as a presenting feature of multiple…
  • 2017 International Congress

    Measuring temporal irregularity in spiral drawings of patients with Parkinson’s disease

    S. Aghanavesi, M. Memedi, J. Westin (Borlange, Sweden)

    Objective: The aim of this work is to evaluate clinimetric properties of a method for measuring Parkinson’s disease (PD) upper limb temporal irregularities during spiral…
  • 2017 International Congress

    Does Parkinsons KinetiGraph (PKG) recording help in clinical decision making? A local experience

    N. Wilson, R. Mappilakkandy, M. Smith, K. Nithi (Northampton, United Kingdom)

    Objective: To evaluate the use of the PKG to aid clinical management decisions in a district general hospital. Background:  Clinicians treating Parkinson's disease (PD) must…
  • 2017 International Congress

    Patients’ Perspective of Physicians’ Counseling on Exercise in Parkinson’s Disease (PD)

    J.Y. Park, V. Shanker (New York, NY, USA)

    Objective: To assess if exercise counseling during appointments translates to knowledge or action in PD patients Background: Aerobic activity can improve motor function, mood, cognition,…
  • 2017 International Congress

    Pairing TMS and physical therapy for treatment of gait and balance disorders in Parkinson’s Disease: a randomized pilot trial

    A. Cucca, H. Migdadi, T. Biller, S. Agarwal, P. Kumar, A. Son, M. Ko, E. Gallo, S. Fisher, A. Di Rocco, M. Biagioni (New York, NY, USA)

    Objective: To explore the feasibility of pairing repetitive transcranial magnetic stimulation (rTMS) back-to-back with standard of care physical therapy (PT) for posture instability and gait…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley